Skip to main content

Table 3 Number of brain regions with glycolytic metabolism outside the reference values

From: Evidence of brain metabolism redistribution from neocortex to primitive brain structures in early acute COVID-19 respiratory syndrome

Brain Area

All patients (n = 23)

High

Low

Normal

Whole Brain

2 (8.7%)

1 (4.3%)

20 (86.9%)

Cerebellum

7 (30.4%)

0 (0%)

16 (69.6%)

Brain Stem

11 (47.8%)

0 (0%)

12 (52.2%)

Basal ganglia

Left

18 (78.3%)

0 (0%)

5 (21.7%)

Right

11 (47.8%)

0 (0%)

12 (52.2%)

Frontal Lobe

Left

1 (4.3%)

6 (26.1%)

16 (69.6%)

Right

0 (0%)

8 (34.8%)

15 (65.2%)

Parietal Lobe

Left

1 (4.3%)

8 (34.8%)

14 (60.9%)

Right

0 (0%)

8 (34.8%)

15 (65.2%)

Temporal Lobe

Left

0 (0%)

5 (21.7%)

18 (78.3%)

Right

0 (0%)

4 (17.4%)

19 (82.6%)

Occipital Lobe

Left

1 (4.3%)

7 (30.4%)

15 (65.2%)

Right

0 (0%)

6 (26.1%)

17 (73.9%)

Caudate Nucleus

Left

6 (26.1%)

0 (0%)

17 (73.9%)

Right

2 (8.7%)

0 (0%)

21 (91.3%)

Lenticular Nucleus

Left

21 (91.3%)

0 (0%)

2 (8.7%)

Right

21 (91.3%)

0 (0%)

2 (8.7%)

Thalamus

Left

16 (69.6%)

0 (0%)

7 (30.4%)

Right

11 (47.8%)

0 (0%)

12 (52.2%)

Hippocampus

Left

10 (43.5%)

1 (4.3%)

12 (52.2%)

Right

9 (39.1%)

1 (4.3%)

13 (56.5%)

Olfactory cortex

Left

5 (21.7%)

0 (0%)

18 (78.3%)

Right

4 (17.4%)

2 (8.7%)

17 (73.9%)